3月24日，诺思兰德今日收盘14.16元，上涨1.43%，最新市净率11.36，总市值38.84亿元。
截至2024年三季报，共有3家机构持仓诺思兰德，其中基金3家，合计持股数567.02万股，持股市值0.65亿元。
北京诺思兰德生物技术股份有限公司是主营业务为基因工程蛋白质类药物、基因治疗药物和眼科用药物的研发、生产及销售。公司主要产品包括基因治疗药物、重组蛋白质类药物、眼科药物。
最新一期业绩显示，2024年三季报，公司实现营业收入5445.08万元，同比13.87%；净利润-34594913.61元，同比28.89%，销售毛利率55.71%。
| 序号 | 股票简称 | PE(TTM) | PE(静) | 市净率 | 总市值(元) |
| 3 | 诺思兰德 | -85.96 | -85.96 | 11.36 | 38.84亿 |
| 行业平均 | 39.31 | 38.72 | 7.41 | 173.27亿 | |
| 行业中值 | 34.99 | 33.28 | 2.83 | 70.17亿 | |
| 1 | 万泰生物 | -284.70 | 67.10 | 6.74 | 837.13亿 |
| 2 | 仁度生物 | -201.42 | -201.42 | 1.60 | 14.86亿 |
| 4 | 诺诚健华 | -79.14 | -47.08 | 4.37 | 297.17亿 |
| 5 | 百济神州 | -62.64 | -62.64 | 12.90 | 3118.28亿 |
| 6 | 四环生物 | -49.96 | -30.91 | 4.98 | 23.27亿 |
| 7 | 双成药业 | -44.83 | -76.82 | 8.98 | 38.98亿 |
| 8 | 近岸蛋白 | -44.16 | -44.16 | 1.13 | 24.20亿 |
| 9 | 益方生物 | -41.51 | -41.51 | 5.88 | 101.97亿 |
| 10 | 康希诺 | -38.42 | -38.42 | 2.87 | 145.55亿 |
| 11 | 艾迪药业 | -30.32 | -30.32 | 3.68 | 39.39亿 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.